Cardlytics, Inc. (CDLX) stock
CDLXNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
$1.34−0.09 (-6.29%)
Close on Nov 13, 2026Market cap $7.89MP/E –Yield –
Cardlytics r&d expenses
Research and development expenses are spending on new products and technology.
Cardlytics's R&D Expenses for the twelve months ending Sep 30, 2026 was $27.83M, down 25.8% year over year. For fiscal 2025 it was $39.77M, down 19.8% from the year before. The highest annual figure on record is $54.44M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.77M | -19.8% |
| FY2024 | Dec 31, 2024 | $49.61M | -3.4% |
| FY2023 | Dec 31, 2023 | $51.35M | -5.7% |
| FY2022 | Dec 31, 2022 | $54.44M | +42.9% |
| FY2021 | Dec 31, 2021 | $38.10M | +117.3% |
| FY2020 | Dec 31, 2020 | $17.53M | +49.9% |
| FY2019 | Dec 31, 2019 | $11.70M | -27.8% |
| FY2018 | Dec 31, 2018 | $16.21M | +33.4% |
| FY2017 | Dec 31, 2017 | $12.15M | -12.6% |
| FY2016 | Dec 31, 2016 | $13.90M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.71M | -50.3% |
| Q2 FY2026 | Jun 30, 2026 | $5.54M | -43.9% |
| Q1 FY2026 | Mar 31, 2026 | $6.43M | -37.4% |
| Q4 FY2025 | Dec 31, 2025 | $12.15M | +22.8% |
| Q3 FY2025 | Sep 30, 2025 | $7.47M | -43.4% |
| Q2 FY2025 | Jun 30, 2025 | $9.87M | -26.7% |
| Q1 FY2025 | Mar 31, 2025 | $10.28M | -21.2% |
| Q4 FY2024 | Dec 31, 2024 | $9.90M | -20.9% |
| Q3 FY2024 | Sep 30, 2024 | $13.19M | +6.1% |
| Q2 FY2024 | Jun 30, 2024 | $13.47M | -9.3% |
| Q1 FY2024 | Mar 31, 2024 | $13.05M | +12.8% |
| Q4 FY2023 | Dec 31, 2023 | $12.51M | -15.5% |
| Q3 FY2023 | Sep 30, 2023 | $12.43M | -9.7% |
| Q2 FY2023 | Jun 30, 2023 | $14.85M | +9.3% |
| Q1 FY2023 | Mar 31, 2023 | $11.56M | -5.9% |
| Q4 FY2022 | Dec 31, 2022 | $14.80M | +25.3% |
| Q3 FY2022 | Sep 30, 2022 | $13.76M | +23.5% |
| Q2 FY2022 | Jun 30, 2022 | $13.58M | +52.0% |
| Q1 FY2022 | Mar 31, 2022 | $12.29M | +97.7% |
| Q4 FY2021 | Dec 31, 2021 | $11.81M | +132.1% |
| Q3 FY2021 | Sep 30, 2021 | $11.14M | +140.8% |
| Q2 FY2021 | Jun 30, 2021 | $8.93M | +125.3% |
| Q1 FY2021 | Mar 31, 2021 | $6.22M | +61.5% |
| Q4 FY2020 | Dec 31, 2020 | $5.09M | +72.0% |
| Q3 FY2020 | Sep 30, 2020 | $4.63M | +53.3% |
| Q2 FY2020 | Jun 30, 2020 | $3.97M | +42.6% |
| Q1 FY2020 | Mar 31, 2020 | $3.85M | +30.9% |
| Q4 FY2019 | Dec 31, 2019 | $2.96M | -21.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.02M | -26.3% |
| Q2 FY2019 | Jun 30, 2019 | $2.78M | -43.1% |
| Q1 FY2019 | Mar 31, 2019 | $2.94M | -15.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.77M | +43.6% |
| Q3 FY2018 | Sep 30, 2018 | $4.10M | +19.8% |
| Q2 FY2018 | Jun 30, 2018 | $4.89M | +58.0% |
| Q1 FY2018 | Mar 31, 2018 | $3.46M | +14.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.62M | – |
| Q3 FY2017 | Sep 30, 2017 | $3.42M | – |
| Q2 FY2017 | Jun 30, 2017 | $3.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.01M | – |
See a number that looks wrong?